Gregory P. Hanson

2015 - MabVax Therapeutics Holdings

In 2015, Gregory P. Hanson earned a total compensation of $2.2M as Chief Financial Officer at MabVax Therapeutics Holdings, a 790% increase compared to previous year.

Compensation breakdown

Bonus$77,175
Option Awards$773,006
Salary$271,819
Stock Awards$1,075,480
Other$19,742
Total$2,217,222

Hanson received $1.1M in stock awards, accounting for 49% of the total pay in 2015.

Hanson also received $77.2K in bonus, $773K in option awards, $271.8K in salary and $19.7K in other compensation.

Rankings

In 2015, Gregory P. Hanson's compensation ranked 4,325th out of 13,638 executives tracked by ExecPay. In other words, Hanson earned more than 68.3% of executives.

ClassificationRankingPercentile
All
4,325
out of 13,638
68th
Division
Manufacturing
1,581
out of 5,187
70th
Major group
Chemicals And Allied Products
573
out of 1,857
69th
Industry group
Drugs
454
out of 1,531
70th
Industry
Pharmaceutical Preparations
357
out of 1,179
70th
Source: SEC filing on May 2, 2017.

Hanson's colleagues

We found three more compensation records of executives who worked with Gregory P. Hanson at MabVax Therapeutics Holdings in 2015.

2015

J Hansen

MabVax Therapeutics Holdings

Chief Executive Officer

2015

Paul Maffuid

MabVax Therapeutics Holdings

Vice President, Pharmaceutical Development and Operations

2015

Wolfgang Scholz

MabVax Therapeutics Holdings

Vice President, Antibody Discovery

You may also like